Blood Irradiation Market Size, Share | Industry Trends 2022, 2028
The blood irradiation market is projected to reach US$ 104.37 million by 2028 from US$ 65.15 million in 2021; it is expected to grow at a CAGR of 7.0% from 2022 to 2028.
The rising prevalence of communicable and noncommunicable disorders and increasing research and development drive the market growth. However, the high cost of blood irradiation restricts the market growth.
Blood irradiation is achieved by exposing the blood to at least 25 Gy (2500 cGy) of radiation in the center of the vessel, preventing the replication and engraftment of immunologically competent donor T leukocytes to the recipient. GvHD caused by transplants from donors is almost always fatal, so patients at risk should receive irradiated blood products as time and resources allow. Clinical indications, including acute leukemia, lymphoma, solid tumors receiving intensive chemotherapy or radiation therapy, exchange transfusions, organ transplant recipients, and preterm infants, require blood irradiation therapy. Patients affected by human immunodeficiency virus/acquired immunodeficiency syndrome do not require blood product irradiation as they have not been reported to be susceptible to post-transfusion graft-to-host disease.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Irradiation Market: Strategic Insights
Blood Irradiation Market
-
CAGR (2021 - 2028)
7.0%
-
Market Size 2021
US$ 65.15 Million
-
Market Size 2028
US$ 104.37 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Typenex Medical LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S p A
- Gamma Service Medical GmbH
- Actemium
- Best Theratronics Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Intravenous Laser Blood Irradiation
- Transcutaneous Laser Blood Irradiation
- Extracorporeal Blood Irradiation
Indication
- Acute Leukemia
- Lymphoma
- Solid Tumors
- Pelvic Tumors
End User
- Hospitals
- Blood Banks
- Diagnostics Clinics
- Research Institutes
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Irradiation Market: Strategic Insights
-
CAGR (2021 - 2028)7.0% -
Market Size 2021
US$ 65.15 Million -
Market Size 2028
US$ 104.37 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Typenex Medical LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S p A
- Gamma Service Medical GmbH
- Actemium
- Best Theratronics Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Intravenous Laser Blood Irradiation
- Transcutaneous Laser Blood Irradiation
- Extracorporeal Blood Irradiation
- Acute Leukemia
- Lymphoma
- Solid Tumors
- Pelvic Tumors
- Hospitals
- Blood Banks
- Diagnostics Clinics
- Research Institutes
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
Increase in Prevalence of Communicable and Noncommunicable Diseases Drives Market Growth
There is an increase in the number of incidence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, owing to a large population across the world susceptible to such conditions. According to World Health Organization (WHO), cardiovascular disorders are the leading cause of death globally, and ~17.9 million deaths are reported yearly. Additionally, the rising prevalence of communicable diseases, such as Hepatitis, influenza, Human Immunodeficiency Virus (HIV), and acquired immunodeficiency syndrome (AIDS), are driving the growth of the blood irradiation market. According to WHO, 325 million people were infected with the hepatitis B virus in 2020, and 900,000 people die from hepatitis B virus infection every year. Moreover, a large geriatric population across the world is contributing to the prevalence of noncommunicable diseases, such as cardiovascular disorders, renal disorders, and strokes. According to WHO, the population of people aged 60 years and above was 1 billion in 2019 and is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is susceptible to noncommunicable disease conditions owing to various factors such as poor nutrition, lack of physical activity, excessive use of tobacco, and consumption of alcohol.
Additionally, surging blood transfusion owing to an increase in surgical procedures, accidents, trauma cases, and disorders, along with the rising prevalence of bloodstream infections, supports the market growth. Bloodstream infections, underlying conditions, and invasive procedures are common among the geriatric population. Bloodstream infections are the major cause of illness and death among large populations. According to the National Library of Medicine, ~28,000 bloodstream infections occur across the world annually. Moreover, rising awareness about bloodstream infections and increasing immune responses to transfused blood can cause complications as increasing use of irradiated blood in cancer treatment strengthens the immune system and improves overall health of patients, which is driving the growth of the blood irradiation market.
Thus, the increase in the prevalence of communicable and noncommunicable disorders, rise in blood transfusion, surge in bloodstream infections, and increase in immune responses are driving the growth of the blood irradiation market.
Type-Based Insights
The blood irradiation market, based on type, is segmented into intravenous laser blood irradiation , transcutaneous laser blood irradiation,and extracorporeal blood irradiation. In 2021, the intravenous laser blood irradiation segment accounted for the largest market share. However, the extracorporeal laser blood irradiation segment is expected to register the highest CAGR of 7.8% during the forecast period.
End User-Based Insights
Based on end user, the blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospitals segment held the largest market share in 2021. However, the blood banks segment is estimated to register the highest CAGR of 7.7% in the market during the forecast period.
Blood Irradiation Market Report Scope
Report Attribute
Details
Market size in 2021
US$ 65.15 Million
Market Size by 2028
US$ 104.37 Million
Global CAGR (2021 - 2028)
7.0%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Type - Intravenous Laser Blood Irradiation
- Transcutaneous Laser Blood Irradiation
- Extracorporeal Blood Irradiation
By Indication - Acute Leukemia
- Lymphoma
- Solid Tumors
- Pelvic Tumors
By End User - Hospitals
- Blood Banks
- Diagnostics Clinics
- Research Institutes
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
- Typenex Medical LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S p A
- Gamma Service Medical GmbH
- Actemium
- Best Theratronics Ltd
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 65.15 Million |
Market Size by 2028 | US$ 104.37 Million |
Global CAGR (2021 - 2028) | 7.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Indication-Based Insights
By indication, the blood irradiation market is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment held the largest market share in 2021. However, the lymphoma segment is estimated to register the highest CAGR of 8.8% in the market during the forecast period.
Companies operating in the blood irradiation market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. For instance, in June 2021, Rad Source Technologies, a commercial X-ray radiation products supplier in the US, designed a product to replace self-shielded gamma irradiators and introduced its newly redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021.
Blood Irradiation Market – by Geography
Geographically, the blood irradiation market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; and Best Theratronics Ltd. are among the market participants included in the research study.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global blood irradiation market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for blood irradiation market. The US is estimated to hold the largest share in the blood irradiation market during the forecast period. Increase in R&D activities along with surge in autoimmune disorders and organ transplants are the contributing factors for the regional growth. Additionally, increase in communicable and non-communicable diseases is the key factor responsible for the Asia-Pacific regional growth for blood irradiation accounting fastest growth of the region during the coming years.
Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; Best Theratronics Ltd. are among the leading companies operating in the global blood irradiation market
The acute leukemia segment dominated the global blood irradiation market and accounted for the largest revenue of 26.93 Mn in 2021.
Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.
Increase in communicable and non-communicable diseases, rise in healthcare expenditure, and government initiatives are the most significant factors responsible for the overall market growth.
Based on type, intravenous laser blood irradiation took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The List of Companies - Blood Irradiation Market
- Typenex Medical, LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S.p.A.
- Gamma-Service Medical GmbH
- Actemium
- Best Theratronics Ltd.